← Back to Search

Behavioral Intervention

Speech Treatment for Minimally Verbal Children with Autism (TxMVASD+CAS Trial)

N/A

Recruiting

Research Sponsored by MGH Institute of Health Professions

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Meets criteria for Childhood Apraxia of Speech

Able to correctly repeat at least 2 syllables

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

TxMVASD+CAS Trial Summary

This trial tests if adding CAS-specific therapy to minimally verbal children with autism will improve their speech development.

Who is the study for?

This trial is for minimally verbal children with Autism Spectrum Disorder who can repeat at least 2 syllables and meet the criteria for Childhood Apraxia of Speech. They should not speak more than 20 words or phrases and must be exposed to English at least half the time. Children with poorly controlled seizures, sensory disabilities, or severe behavioral issues cannot participate.Check my eligibility

What is being tested?

The study tests a speech treatment designed specifically for children with both autism and CAS (a speech movement planning disorder). It aims to see if this tailored therapy helps improve their ability to speak.See study design

What are the potential side effects?

Since this is a speech therapy intervention, traditional medication side effects are not expected. However, there may be fatigue or frustration during treatment sessions due to the challenges associated with learning new speech skills.

TxMVASD+CAS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Childhood Apraxia of Speech.

Select...

I can repeat at least two syllables correctly.

TxMVASD+CAS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Attempts Correct

Phonemes Correct

Secondary outcome measures

Lip aperture movement variability

Phoneme distinctiveness

TxMVASD+CAS Trial Design

1Treatment groups

Experimental Treatment

Group I: CAS Treatment for MV ASDExperimental Treatment1 Intervention

Participants will receive CAS treatment, modified for minimally verbal children with autism

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

MGH Institute of Health ProfessionsLead Sponsor

15 Previous Clinical Trials

3,635 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who satisfies the criteria to be a participant of this clinical experiment?

"This investigation is searching for 20 individuals with autism spectrum disorder that are between 5 and 18 years old. Most notably, participants should possess the following qualifications: manifestations of Autism Spectrum Disorder, utter at least two syllables correctly, eligibility criteria for Childhood Apraxia of Speech met, only capable of vocalizing up to twenty distinct words with no phrase speech in language sample; must be regularly exposed to English at least fifty percent of their time."

Answered by AI

How many participants are being enlisted in this clinical investigation?

"Affirmative. Clinicaltrials.gov states that this clinical trial, which was initially announced on January 1st 2024, is seeking enrolment of 20 patients from a single site. The information has been updated most recently on November 7th 2023."

Answered by AI

Does the minimum age requirement for this clinical trial extend beyond 40 years?

"The scope of this medical trial is restricted to participants ages 5 - 18, and there are currently 259 studies enrolling these age cohorts. For those over 65 years old, 59 trials have been identified."

Answered by AI

Are there still opportunities to join this research endeavor?

"Based on the information hosted by clinicaltrials.gov, this research is actively seeking participants. An initial posting was made on January 1st 2024 and the most recent update occurred on November 7th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Speech Treatment for Minimally Verbal Children With ASD and CAS

Karen Chenausky, Ph.D., CCC-SLP 2024. "Speech Treatment for Minimally Verbal Children With ASD and CAS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05066178.

All > Asd > Autism